ResMed Inc. RMD
222.00
0.11
0.05%
as of 25 Sep
- Market cap
- $31.9B
- P/E
- 21.3×
Follow RMD
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
ResMed Inc. (RMD) Operating margin
ResMed Inc.'s operating margin over the twelve months to 30 June 2026 was 33.4%. Over the past ten years it has ranged from 20.6% (fiscal 2017) to 33.4% (fiscal 2026) — the current reading is the highest in ten years. That is above the Medical Instruments & Supplies industry median of 1.64% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Annual
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2026 | 33.4% | 0.62 |
| FY2025 | 32.8% | 4.58 |
| FY2024 | 28.2% | 1.37 |
| FY2023 | 26.8% | (1.16) |
| FY2022 | 28.0% | (0.31) |
| FY2021 | 28.3% | 0.89 |
| FY2020 | 27.4% | 5.16 |
| FY2019 | 22.2% | (0.93) |
| FY2018 | 23.2% | 2.55 |
| FY2017 | 20.6% | (2.73) |
Quarterly
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 30.7% | (4.26) |
| Mar 2026 | 34.9% | 0.36 |
| Dec 2025 | 34.6% | 1.13 |
| Sep 2025 | 33.4% | (0.29) |
| 42 more quarters | Free account |
Against its own ten years
Low 20.6%
High 33.4%
Ten-year median
27.1%
Current reading's percentile
100
Operating margin against peers
| Company | Operating margin |
|---|---|
| RMD ResMed Inc. | 33.4% |
| MDLN Medline Inc. compare | 31.1% |
| SOLV Solventum Corporation compare | 25.0% |
| WST West Pharmaceutical Services, Inc. compare | 20.5% |
| COO The Cooper Companies, Inc. compare | 12.8% |
| BDX Becton, Dickinson and Company compare | 10.3% |
| ALC Alcon compare | 8.73% |
| RGEN Repligen Corporation compare | 8.23% |
| BAX Baxter International Inc. compare | −2.39% |
| Medical Instruments & Supplies industry median | 1.64% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on RMD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement